Show results for
Refine by
Cancer Patient Suppliers Serving Togo
105 companies found
based inRoorkee, INDIA
Hiral Labs Limited is pharmaceutical formulation company engaged in manufacturing and marketing of finished pharmaceutical products since year October 2000. We are accredited with WHO: GMP and ISO 9001:2008 certification. In domestic market more ...
based inPhiladelphia, PENNSYLVANIA (USA)
Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4, ADP-A2M4CD8, and ADP-A2AFP) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity ...
Our goal is to revolutionize cancer therapy on a global basis by developing TCR T-cell therapies (called SPEAR T-cells) with the potential to treat a wide range of cancer types and patients. Our TCR ...
based inMiami, FLORIDA (USA)
At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions. OPKO has grown into a global ...
OPK88004 is being assessed as a treatment for muscle wasting, decreased physical strength and function, sarcopenia, and frailty in end stage renal disease (ESRD) patients on dialysis and for prostate cancer ...
based inSon, NETHERLANDS
Microsure is a medical device company located in Eindhoven (Netherlands) founded by Eindhoven University of Technology and Maastricht University Medical Center in 2016. Our focus is to improve patient’s lives through developing robot systems for ...
LVA or lymph node reconstruction for various indications. The use of a dedicated robot for microsurgery in treating breast cancer-related lymphedema. Women with breast cancer are often treated with (partial) breast and axillary tissue resection and ...
based inSan Diego, CALIFORNIA (USA)
We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...
based inWoburn, MASSACHUSETTS (USA)
Sirtex is a company specializing in the manufacture of SIR-Spheres® Y-90 resin microspheres, which are medical devices indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary ...
based inCambridge, MASSACHUSETTS (USA)
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer. Leveraging decades of industry learnings, we have developed proprietary and highly ...
UpRi, a first-in-class ADC targeting the sodium-dependent phosphate transport protein NaPi2b, utilizes the Dolaflexin platform to deliver about 10 DolaLock payload molecules per antibody. The NaPi2b antigen is broadly expressed in ovarian ...
based inIsfiya, ISRAEL
At Check-Cap our experienced and motivated team is committed to increasing screening adherence and helping to reduce the global incidence of colorectal cancer (CRC) through cancer prevention. Our patented technology C-Scan is the first and only ...
based inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Immatics is developing Adoptive Cell Therapies, which are designed to leverage the power of T cells to actively infiltrate tumor tissue and kill tumor cells in a specific and serial ...
based inStafford, VIRGINIA (USA)
We are Hyper-accelerate drug and medical device development. Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to ...
A tool that performs in silico clinical trials to assess the neutropenic effects of a chemotherapeutic agent in a virtual population of cancer patients ...
based inNew York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per year over the next two decades, causing deaths to rise to 13M per ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
based inDenver, COLORADO (USA)
Fischer Imaging is focused on improving outcomes for cancer patients with advanced imaging. Our proprietary technology doubles the resolution and contrast of today’s mammography using less than half the x-ray dose and removes the need for painful ...
based inParis, FRANCE
Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented by French ...
based inChangning District, CHINA
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative ...
based inDunedin,, NEW ZEALAND
Pacific Edge is a cancer diagnostics company. We specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Our ...
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder ...
based inParis, FRANCE
SIVAN is an e-health company committed to improve the lives of cancer patients worldwide. SIVAN developed Moovcare, the first application that was clinically validated and proven to extend the life of lung cancer patients. Moovcare helps physicians ...
Moovcare® is a digital therapeutic that uses a simple weekly questionnaire to detect relapse or complication during follow-up of lung cancer patients. A Class I medical device, Moovcare has been proven in ...
based inOslo, NORWAY
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer ...
Recent advances in the field of immuno-oncology have established that mutated antigens (neoantigens), are viable targets of the immune system, potentially specific to each individual cancer patient. This plus many ...